1. A multiplex platform for the identification of ovarian cancer biomarkers
   Kristin L. M. Boylan et al, 2017, Clin Proteom CrossRef
2. CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer
   Yichou Wei et al, 2017, Cancer Immunol Immunother CrossRef
3. CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients
   Judith N. Wagner et al, 2017, J Neurol CrossRef
4. Up-regulation of chemokine CXCL13 in systemic candidiasis
   Congya Li et al, 2017, Clinical Immunology CrossRef
5. CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
   Santosh Kumar Singh et al, 2018, Sci Rep CrossRef
6. Inflammatory Alteration of Human T Cells Exposed Continuously to Asbestos
   Naoko Kumagai-Takei et al, 2018, IJMS CrossRef
7. null
   W. Naumnik et al, 2018 CrossRef
8. Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma
   Mano Nakamura et al, 2019, OncoImmunology CrossRef
9. Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel
   Neeraj Kapur et al, 2019, Cancer Letters CrossRef
10. CXCL13/CXCR5 signaling axis in cancer
    Muzammal Hussain et al, 2019, Life Sciences CrossRef
11. CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond
    Marcelo G. Kazanietz et al, 2019, Front. Endocrinol. CrossRef
12. null
    Aliyah M. Weinstein et al, 2015 CrossRef
13. CXCL13 rather than IL-31 is a potential indicator in patients with hepatocellular carcinoma
    Bing Li et al, 2017, Cytokine CrossRef
14. Detection and Quantification of GPCR mRNA: An Assessment and Implications of Data from High-Content Methods
    Krishna Sriram et al, 2019, ACS Omega CrossRef
15. Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment
    Adaugo Q. Ohandjo et al, 2019, Sci Rep CrossRef
16. Serum TNFRII: A promising biomarker for predicting the risk of subcentimetre lung adenocarcinoma
    Minjuan Hu et al, 2020, J Cell Mol Med CrossRef
17. Identification and Analysis of Dysfunctional Genes and Pathways in CD8+ T Cells of Non-Small Cell Lung Cancer Based on RNA Sequencing
    Xuefang Tao et al, 2020, Front. Genet. CrossRef
18. MDC and BLC are independently associated with the significant risk of early stage lung adenocarcinoma
    Yanwei Zhang et al, 2016, Oncotarget CrossRef
19. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer
    Lijuan Lyu et al, 2020, International Immunopharmacology CrossRef
20. Correlation between CXCR4, CXCR5 and CCR7 expression and survival outcomes in patients with clinical T1N0M0 non-small cell lung cancer.
    Zhao Yue et al, 2020, Thorac Cancer CrossRef
21. The N-terminal length and side-chain composition of CXCL13 affect crystallization, structure and functional activity
    Eric M. Rosenberg et al, 2020, Acta Crystallogr D Struct Biol CrossRef
22. Comprehensive genomic and immunophenotypic analysis of CD4 T cell infiltrating human triple-negative breast cancer
    He Zhang et al, 2020, Cancer Immunol Immunother CrossRef
23. Cellular Therapy for the Treatment of Solid Tumors
    Joseph M. Grimes et al, 2021, Transfusion and Apheresis Science CrossRef
24. Intratumoral CXCL13⁺CD8⁺T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma.
    Siyuan Dai et al, 2021, J Immunother Cancer CrossRef
25. Prognostic significance of eight immune-related genes on survival in patients with lung squamous cell carcinoma
    Hansheng Wu et al, 2021, Biomarkers in Medicine CrossRef
26. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis
    Jing Zhang et al, 2021, BioMed Research International CrossRef
27. CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma-Diagnostic, Therapeutic, and Prognostic Relevance.
    Ilias Masouris et al, 2021, Front Neurol CrossRef
28. Circulating Biomarkers of Inflammation and Ovarian Cancer Risk in the Nurses' Health Studies.
    Lauren C Peres et al, 2021, Cancer Epidemiol Biomarkers Prev CrossRef
29. Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients
    Kaifeng Jin et al, 2021, OncoImmunology CrossRef
30. Expression and prognostic value of TRPM7 in canine mammary tumours.
    Seulji Lee et al, 2021, Vet Comp Oncol CrossRef
31. CXCL13 Signaling in the Tumor Microenvironment.
    Guangbiao Zhou, 0 CrossRef
32. CXC chemokine ligand‐13 promotes metastasis via CXCR5‐dependent signaling pathway in non‐small cell lung cancer
    Chia‐Chia Chao et al, 2021, J Cell Mol Med CrossRef
33. CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells
    Guangchao Li et al, 2021, Molecular Therapy - Oncolytics CrossRef
34. CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities.
    Guangbiao Zhou, 0 CrossRef
35. Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
    Ching-Hung Hsieh et al, 2022, Cancers CrossRef
36. Elevated Plasma Levels of CXCL13 Chemokine in Saudi Patients With Asthma Exacerbation.
    Wael Alturaiki, 2022, Cureus CrossRef
37. An Integrated Pan-Cancer Analysis of 33 Human Cancers Reveals the Potential Clinical Implications and Immunotherapeutic Value of C-X-C Motif Chemokine Ligand 13
    Huanyu Zhang et al, 2022, Front. Oncol. CrossRef
38. Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer
    Caili Xu et al, 2022 CrossRef
39. Bioinformatics Analysis of Prognostic Significance and Immune Characteristics of CXC Chemokine Family in Patients with Lung Adenocarcinoma
    Dachen Bian et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
40. Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma
    Yiming Shen et al, 2022, World J Surg Onc CrossRef
41. CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer
    Binhan Wang et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
42. CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
    Kayode Komolafe et al, 2022, International Journal of Inflammation CrossRef
43. CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression
    Katia Beider et al, 2022, J Hematol Oncol CrossRef
44. Comprehensive analysis of chemokines family and related regulatory ceRNA network in lung adenocarcinoma
    Yifan Hu et al, 2022, Heliyon CrossRef
45. Circ-PGAM1 Enhances Matrine Resistance of Non-Small Cell Lung Cancer via the miR-326/CXCR5 Axis
    Caijun Dong et al, 2022, Cancer Biotherapy and Radiopharmaceuticals CrossRef
46. The synergized diagnostic value of VTQ with chemokine CXCL13 in lung tumors
    Xu Zhang et al, 2023, Front. Oncol. CrossRef
47. A pyroptosis-related gene signature that predicts immune infiltration and prognosis in colon cancer
    Mingjian Wu et al, 2023, Front. Oncol. CrossRef
48. Clinical markers predict the efficacy of several immune checkpoint inhibitors in patients with non-small cell lung cancer in China
    Yuxin Wang et al, 2023, Front. Immunol. CrossRef
49. Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy
    Giulia Petroni et al, 2024 CrossRef
50. Intrauterine adhesions repair with menstrual blood-derived mesenchymal stem cells via CXCL13-CXCR5 signal axis and its mechanism
    Bing Luo et al, 2024, Stem Cell Res Ther CrossRef